PROFESSIONAL EDITION

The largest community of pharma leaders

Propanc Biopharma Appoints Carlo Campiciano as Chief Financial Officer

MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”, the “Company”, “we”, “our”, or “us”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that Propanc has appointed Mr. Carlo Campiciano as its Chief Financial Officer, commencing July 1, 2019. Mr. Campiciano brings significant experience to the Company across a broad range of financial disciplines in the healthcare sector….

 

 

http://www.businesswire.com/news/home/20190624005136/en/Propanc-Biopharma-Appoints-Carlo-Campiciano-Chief-Financial/

Recent Articles